Is a diabetes drug the key to aggressive breast cancer?

New research finds that the diabetes drug metformin changes stem cancer cells in a way that makes them easier to target with a new form of treatment. The findings could help treat triple-negative breast cancer, which is particularly aggressive.

Triple-negative breast cancer is an aggressive form of breast cancer that often results in a poor outlook for people who receive a diagnosis for it.

Full article HERE